Overview
David Ellent is a Hematologist Oncology specialist and a Radiation Oncologist in Spring, Texas. Dr. Ellent is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Inflammatory Breast Cancer, and Small Cell Lung Cancer (SCLC). Dr. Ellent is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2255 E Mossy Oaks Rd, Suite 500, Spring, TX 77389
UT Physicians
Syed Jafri is a Hematologist Oncology specialist and an Oncologist in Sugar Land, Texas. Dr. Jafri is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Jafri is currently accepting new patients.
MD Anderson
Anne Tsao is an Oncologist and a Hematologist in Houston, Texas. Dr. Tsao is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.
Frank Mott is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Mott is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, and Squamous Cell Lung Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult T-Cell LeukemiaDr. Ellent isAdvanced. Learn about Adult T-Cell Leukemia.
- Breast CancerDr. Ellent isAdvanced. Learn about Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)
- Chronic T-Cell Leukemia (CTCL)Dr. Ellent isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Inflammatory Breast CancerDr. Ellent isAdvanced. Learn about Inflammatory Breast Cancer.
- Iron Deficiency AnemiaDr. Ellent isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acute Mountain SicknessDr. Ellent isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Ellent isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Ellent isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Ellent isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ellent isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anaplastic Thyroid CancerDr. Ellent isExperienced. Learn about Anaplastic Thyroid Cancer.